Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study investigates hidden immune risks of pregnancy after lung transplant

NCT ID NCT05689905

First seen Mar 21, 2026 · Last updated May 20, 2026 · Updated 13 times

Summary

This study looked at 11 children born to women who had lung transplants to see if shared immune markers (HLA types) between the child and the lung donor increase the mother's risk of organ rejection. Researchers collected cheek swabs from the children to compare their HLA types with the mother and donor. The goal is to better understand pregnancy risks and create safer recommendations for transplant patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • AP-HM

    Marseille, 13005, France

  • Bordeaux University Hospital

    Bordeaux, 33000, France

  • Civils Hospitals Lyon

    Lyon, 69002, France

  • Cochin Hospital (AP-HP)

    Paris, 75014, France

  • Foch Hospital

    Suresnes, 92150, France

  • Grenoble University Hospital

    Grenoble, 38700, France

  • Marie Lannelongue Hospital (GHSJ)

    Le Plessis-Robinson, 92350, France

  • Nantes University Hospital

    Nantes, Loire Atlantique, 44093, France

  • Strasbourg University Hospital

    Strasbourg, 67200, France

Conditions

Explore the condition pages connected to this study.